+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Animal Pharmaceuticals Market - Global Forecast 2026-2032- Product Image
Animal Pharmaceuticals Market - Global Forecast 2026-2032- Product Image
Sale

Animal Pharmaceuticals Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5337791
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Animal Pharmaceuticals Market is projected to reach USD 47.54 Billion in 2026. It is expected to continue growing at a CAGR of 8.50%, reaching USD 77.71 Billion by 2032.

The animal pharmaceuticals market is being shaped by the convergence of livestock productivity, companion animal wellness, zoonotic disease preparedness, and antimicrobial stewardship. Veterinary pharmaceuticals, including parasiticides, anti-infectives, vaccines, anti-inflammatory drugs, dermatology therapies, reproductive products, and pain management medicines, remain essential to animal health, food security, and public health resilience.

Verified signals from organizations such as WOAH, FAO, USDA, FDA, and EMA show sustained demand for science-backed medicines that improve animal welfare while reducing disease-related production losses. Growth is strongest where veterinary access, pet insurance adoption, herd health programs, cold-chain capability, and regulatory modernization support earlier diagnosis, preventive care, and responsible treatment.

Transformative Shifts Reshaping Animal Health

The competitive landscape is shifting from volume-led therapeutics toward precision prevention, compliance-ready manufacturing, and data-enabled veterinary care. Livestock producers are prioritizing vaccines, diagnostics-linked treatment, and biosecurity programs as avian influenza, African swine fever, foot-and-mouth disease, and other transboundary animal diseases continue to affect global supply chains.

In companion animals, longer pet lifespans and humanization of pets are expanding demand for chronic care medicines, oncology support, dermatology drugs, pain therapies, and specialty injectables. At the same time, tighter antimicrobial use rules in the United States, European Union, and other regulated markets are accelerating innovation in alternatives such as vaccines, immunomodulators, microbiome products, improved husbandry protocols, and targeted therapeutics.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative force across veterinary drug discovery, pharmacovigilance, manufacturing quality, and field disease surveillance. AI-enabled modeling can help screen compounds, identify adverse event patterns, detect outbreak signals, and optimize clinical study design, reducing uncertainty across long development cycles.

In commercial operations, machine learning is improving demand planning for seasonal parasiticides, biologics cold-chain management, and inventory allocation across veterinary clinics, pharmacies, and livestock channels. The highest-value applications are those paired with validated datasets, regulatory traceability, cybersecurity controls, veterinarian oversight, and explainable models that support, not replace, clinical judgment.

Key Regional Insights in Animal Pharmaceuticals

Asia-Pacific is a major growth engine due to large livestock populations, expanding protein consumption, aquaculture intensity, and rising veterinary infrastructure in China, India, Japan, South Korea, Australia, and ASEAN markets. WOAH and FAO disease monitoring continue to highlight the importance of vaccination, parasite control, and biosecurity across the region. North America remains one of the most innovation-intensive regions, supported by strong companion animal spending, FDA-regulated product pathways, pet insurance penetration, established distribution networks, and advanced livestock health systems.

Europe is defined by strict EMA oversight, One Health policies, and reduced antimicrobial use targets, which favor vaccines, diagnostics-linked treatment, pharmacovigilance, and high-compliance manufacturing. Latin America, led by Brazil and Mexico, benefits from export-oriented cattle, poultry, and swine production, where disease prevention and residue compliance are central to market access. The Middle East is investing in food security, equine and camel health, and premium pet care, while Africa shows long-term potential through livestock vaccination, parasite control, public-sector disease programs, and wider access to essential veterinary medicines.

Key Group Insights Across Strategic Markets

ASEAN demand is influenced by poultry, aquaculture, and swine production, with biosecurity, vaccine access, and veterinary extension becoming central to animal health planning. The GCC is increasingly focused on food security, camel and equine care, and companion animal services, supported by premium veterinary clinics, regulated import pathways, and demand for quality-assured pharmaceutical supply.

The European Union sets a global benchmark for veterinary medicine regulation, pharmacovigilance, residue monitoring, and antimicrobial stewardship under harmonized rules. BRICS countries combine large livestock bases, expanding pet ownership, local manufacturing priorities, and improving veterinary access. G7 markets drive R&D, premium therapeutics, biologics quality standards, and advanced pharmacovigilance, while NATO members generally emphasize supply-chain resilience, disease surveillance, and preparedness for zoonotic and cross-border animal health threats.

Key Country Insights for Veterinary Pharmaceuticals

The United States leads in companion animal therapeutics, livestock biologics, prescription channel development, and regulatory transparency through FDA CVM and USDA oversight, while Canada emphasizes high-quality veterinary access, animal welfare, and responsible antimicrobial use. Mexico and Brazil are important livestock medicine markets, with Brazil’s cattle, poultry, and swine industries supporting sustained demand for vaccines, parasiticides, reproductive products, and herd health solutions aligned with export requirements.

The United Kingdom, Germany, France, Italy, and Spain reflect Europe’s shift toward stewardship-led prescribing, preventive medicine, and strong pharmacovigilance, while Russia remains tied to domestic livestock production, vaccination programs, and import substitution. China and India are central to Asia’s volume growth due to large livestock populations, expanding companion animal care, and evolving regulatory oversight. Japan and South Korea favor premium companion animal care, advanced therapeutics, and high clinical standards, while Australia combines export livestock biosecurity, parasite control, and strong veterinary governance.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize differentiated portfolios that balance companion animal specialty care with livestock prevention, including vaccines, parasiticides, anti-inflammatory therapies, dermatology products, pain management medicines, and targeted anti-infectives aligned with antimicrobial stewardship. Investment in pharmacovigilance, real-world evidence, quality systems, and lifecycle management can strengthen regulatory confidence and brand durability.

Companies should also expand regional manufacturing resilience, cold-chain reliability, veterinarian education, and digital engagement with clinics, pharmacies, and producers. Strategic partnerships with diagnostics providers, universities, contract manufacturers, public health agencies, and animal health distributors can accelerate access while supporting evidence-based use across developed and emerging markets.

Research Methodology

This executive summary applies a structured secondary research methodology using verified public sources, regulatory databases, scientific literature, trade statistics, veterinary association publications, and animal disease surveillance resources. Key references include authorities such as WOAH, FAO, FDA, USDA, EMA, national veterinary agencies, and peer-reviewed journals.

Insights are triangulated across product categories, species segments, regional regulations, supply-chain indicators, disease surveillance data, antimicrobial stewardship policies, and end-user demand patterns. The analysis emphasizes data-backed market signals, policy direction, technology adoption, and commercially relevant shifts without relying on unverified claims, market sizing, market share, or unsupported projections.

Conclusion: Growth Through Science, Access, and Stewardship

The animal pharmaceuticals market is entering a more evidence-driven phase where growth depends on innovation, stewardship, access, and trust. Demand for veterinary medicines is supported by pet humanization, protein security, disease prevention, and the need to protect animal and human health under the One Health framework.

Winning organizations will be those that combine regulatory excellence, AI-enabled intelligence, resilient supply chains, and clinically meaningful products. As regional needs diverge, scalable portfolios, responsible antimicrobial strategies, and localized market access models will be essential to sustained leadership in animal pharmaceuticals.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Animal Pharmaceuticals Market, by Product Type
7.1. Introduction
7.2. Anesthetics
7.3. Anti-Inflammatory Medications
7.4. Antibiotics
7.4.1. Fluoroquinolones
7.4.2. Macrolides
7.4.3. Penicillins
7.4.4. Sulfonamides
7.4.5. Tetracyclines
7.5. Hormones & Growth Regulators
7.6. Parasiticides
7.6.1. Anthelmintics
7.6.2. Ectoparasiticides
7.7. Vaccines
7.7.1. Inactivated Vaccines
7.7.2. Live Attenuated Vaccines
7.7.3. Subunit Vaccines
8. Animal Pharmaceuticals Market, by Species
8.1. Introduction
8.2. Aquatic Animals
8.3. Birds
8.4. Companion Animals
8.4.1. Cats
8.4.2. Dogs
8.4.3. Horses
8.5. Livestock Animals
8.5.1. Cattle
8.5.2. Poultry
8.5.3. Sheep & Goats
8.5.4. Swine
8.6. Wild Animals
9. Animal Pharmaceuticals Market, by Route of Administration
9.1. Introduction
9.2. Oral
9.2.1. Capsules
9.2.2. Liquid solutions
9.2.3. Powders
9.2.4. Tablets
9.3. Parenteral
9.4. Topical
9.4.1. Creams
9.4.2. Ointments
9.4.3. Sprays
10. Animal Pharmaceuticals Market, by Disease Type
10.1. Introduction
10.2. Infectious Diseases
10.2.1. Bacterial Infections
10.2.2. Fungal Infections
10.2.3. Parasitic Infestations
10.2.4. Viral Infections
10.3. Non-Infectious Diseases
10.3.1. Inflammatory Diseases
10.3.2. Metabolic Disorders
10.3.3. Nutritional Deficiencies
10.3.4. Reproductive Disorders
11. Animal Pharmaceuticals Market, by End User
11.1. Introduction
11.2. Government & Public Health Organizations
11.3. Livestock Farms & Poultry Farms
11.4. Pet Owners
11.5. Research Institutions
11.6. Veterinary Clinics & Hospitals
12. Animal Pharmaceuticals Market, by Distribution Channels
12.1. Introduction
12.2. Offline Pharmacies
12.3. Online Pharmacies
13. Animal Pharmaceuticals Market, by Region
13.1. Asia-Pacific
13.2. Europe
13.3. North America
13.4. Latin America
13.5. Africa
13.6. Middle East
14. Animal Pharmaceuticals Market, by Group
14.1. NATO
14.2. G7
14.3. BRICS
14.4. European Union
14.5. ASEAN
14.6. GCC
15. Animal Pharmaceuticals Market, by Country
15.1. China
15.2. United States
15.3. Japan
15.4. India
15.5. Germany
15.6. United Kingdom
15.7. Australia
15.8. France
15.9. South Korea
15.10. Italy
15.11. Canada
15.12. Russia
15.13. Brazil
15.14. Mexico
15.15. Spain
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Aurora Pharmaceutical, Inc.
17.2. Bimeda Inc.
17.3. Biogénesis Bagó S.A.
17.4. Biovac Ltd.
17.5. Boehringer Ingelheim International GmbH
17.6. Ceva Santé Animale
17.7. Chanelle Pharma
17.8. China Animal Husbandry Industry Co., Ltd.
17.9. Dechra Pharmaceuticals PLC
17.10. ECO Animal Health Group PLC
17.11. Elanco Animal Health Incorporated
17.12. Hester Biosciences Limited
17.13. Huvepharma, Inc.
17.14. Indian Immunologicals Ltd.
17.15. Intas Pharmaceuticals Ltd.
17.16. Laboratorio Drag Pharma Chile Invetec S.A.
17.17. Merck & Co., Inc.
17.18. Neogen Corporation
17.19. Nippon Zenyaku Kogyo Co., Ltd.
17.20. Norbrook Group
17.21. Nutramax Laboratories Veterinary Sciences, Inc
17.22. Orion Corporation
17.23. PetIQ, LLC
17.24. Phibro Animal Health Corporation
17.25. Teknofarma S.r.l.
17.26. Veterinary Pharmaceutical Solutions
17.27. Vetoquinol Group
17.28. Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
17.29. Virbac S.A.
17.30. Zendal Group
17.31. Zoetis Inc.
List of Figures
FIGURE 1. GLOBAL ANIMAL PHARMACEUTICALS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ANIMAL PHARMACEUTICALS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ANIMAL PHARMACEUTICALS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ANIMAL PHARMACEUTICALS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL ANIMAL PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ANIMAL PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ANESTHETICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ANESTHETICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ANESTHETICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ANTI-INFLAMMATORY MEDICATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ANTI-INFLAMMATORY MEDICATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ANTI-INFLAMMATORY MEDICATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL ANTIBIOTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL ANTIBIOTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL FLUOROQUINOLONES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL MACROLIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL MACROLIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL MACROLIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL PENICILLINS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL PENICILLINS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL PENICILLINS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL SULFONAMIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL SULFONAMIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SULFONAMIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL TETRACYCLINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL TETRACYCLINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL TETRACYCLINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL HORMONES & GROWTH REGULATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL HORMONES & GROWTH REGULATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL HORMONES & GROWTH REGULATORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL PARASITICIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL PARASITICIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL PARASITICIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ANTHELMINTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ANTHELMINTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ANTHELMINTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL ECTOPARASITICIDES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL INACTIVATED VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL LIVE ATTENUATED VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL SUBUNIT VACCINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL AQUATIC ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL AQUATIC ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL AQUATIC ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL BIRDS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL BIRDS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL BIRDS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL CATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL CATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL DOGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL DOGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL HORSES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL HORSES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL HORSES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL LIVESTOCK ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL CATTLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL POULTRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL SHEEP & GOATS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL SHEEP & GOATS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL SHEEP & GOATS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL SWINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL SWINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL WILD ANIMALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL WILD ANIMALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL WILD ANIMALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL ORAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL ORAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL ORAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL CAPSULES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL CAPSULES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL CAPSULES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL LIQUID SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL LIQUID SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL LIQUID SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL POWDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL POWDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL POWDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL TABLETS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL TABLETS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL TABLETS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL PARENTERAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL PARENTERAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL PARENTERAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL TOPICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL TOPICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL TOPICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL CREAMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL CREAMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL CREAMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL OINTMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL OINTMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL OINTMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL SPRAYS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL SPRAYS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL SPRAYS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL PARASITIC INFESTATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL PARASITIC INFESTATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL PARASITIC INFESTATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL NON-INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL NON-INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL NON-INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL INFLAMMATORY DISEASES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL INFLAMMATORY DISEASES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL INFLAMMATORY DISEASES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL METABOLIC DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL NUTRITIONAL DEFICIENCIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL NUTRITIONAL DEFICIENCIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL NUTRITIONAL DEFICIENCIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL REPRODUCTIVE DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL REPRODUCTIVE DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL REPRODUCTIVE DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL GOVERNMENT & PUBLIC HEALTH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL GOVERNMENT & PUBLIC HEALTH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL GOVERNMENT & PUBLIC HEALTH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL LIVESTOCK FARMS & POULTRY FARMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL LIVESTOCK FARMS & POULTRY FARMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL LIVESTOCK FARMS & POULTRY FARMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL PET OWNERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 159. GLOBAL PET OWNERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL PET OWNERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 161. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 163. GLOBAL RESEARCH INSTITUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 164. GLOBAL VETERINARY CLINICS & HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 165. GLOBAL VETERINARY CLINICS & HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 166. GLOBAL VETERINARY CLINICS & HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 167. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2017-2032 (USD MILLION)
TABLE 168. GLOBAL OFFLINE PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 169. GLOBAL OFFLINE PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 170. GLOBAL OFFLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 171. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 172. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 173. GLOBAL ONLINE PHARMACIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 174. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2017-2032 (USD MILLION)
TABLE 191. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 192. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 193. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 194. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 195. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 196. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 197. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 198. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 199. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 200. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 201. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 202. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 203. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 204. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 205. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 206. EUROPE ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2017-2032 (USD MILLION)
TABLE 207. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 208. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 209. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 210. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 211. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 212. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 213. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 214. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 215. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 216. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 217. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 218. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 219. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 220. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 221. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 222. NORTH AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2017-2032 (USD MILLION)
TABLE 223. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 224. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 225. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 226. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 227. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 228. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 229. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 230. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 231. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 232. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 233. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 234. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 235. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 236. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 237. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 238. LATIN AMERICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2017-2032 (USD MILLION)
TABLE 239. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 240. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 241. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 242. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 243. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 244. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 245. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 246. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 247. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 248. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 249. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 250. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 251. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 252. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 253. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 254. AFRICA ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2017-2032 (USD MILLION)
TABLE 255. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 256. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 257. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 258. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 259. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 260. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 261. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 262. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 263. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 264. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 265. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 266. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 267. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 268. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 269. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 270. MIDDLE EAST ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2017-2032 (USD MILLION)
TABLE 271. GLOBAL ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 272. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 273. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 274. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 275. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 276. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 277. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 278. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 279. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 280. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 281. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 282. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 283. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 284. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 285. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 286. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 287. NATO ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2017-2032 (USD MILLION)
TABLE 288. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 289. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 290. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 291. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 292. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 293. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 294. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 295. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 296. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 297. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 298. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 299. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 300. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 301. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 302. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 303. G7 ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2017-2032 (USD MILLION)
TABLE 304. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 305. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 306. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 307. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 308. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 309. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 310. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 311. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 312. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 313. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 314. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 315. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 316. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 317. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 318. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 319. BRICS ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2017-2032 (USD MILLION)
TABLE 320. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 321. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 322. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 323. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 324. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 325. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 326. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 327. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 328. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 329. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 330. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 331. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 332. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 333. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 334. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 335. EUROPEAN UNION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2017-2032 (USD MILLION)
TABLE 336. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 337. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 338. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 339. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 340. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 341. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 342. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 343. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 344. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 345. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 346. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 347. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 348. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 349. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY NON-INFECTIOUS DISEASES, 2017-2032 (USD MILLION)
TABLE 350. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 351. ASEAN ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2017-2032 (USD MILLION)
TABLE 352. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 353. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 354. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTIBIOTICS, 2017-2032 (USD MILLION)
TABLE 355. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, 2017-2032 (USD MILLION)
TABLE 356. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, 2017-2032 (USD MILLION)
TABLE 357. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY SPECIES, 2017-2032 (USD MILLION)
TABLE 358. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY COMPANION ANIMALS, 2017-2032 (USD MILLION)
TABLE 359. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY LIVESTOCK ANIMALS, 2017-2032 (USD MILLION)
TABLE 360. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2017-2032 (USD MILLION)
TABLE 361. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORAL, 2017-2032 (USD MILLION)
TABLE 362. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY TOPICAL, 2017-2032 (USD MILLION)
TABLE 363. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISEASE TYPE, 2017-2032 (USD MILLION)
TABLE 364. GCC ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, 2017-2032

Companies Mentioned

  • Aurora Pharmaceutical, Inc.
  • Bimeda Inc.
  • Biogénesis Bagó S.A.
  • Biovac Ltd.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale
  • Chanelle Pharma
  • China Animal Husbandry Industry Co., Ltd.
  • Dechra Pharmaceuticals PLC
  • ECO Animal Health Group PLC
  • Elanco Animal Health Incorporated
  • Hester Biosciences Limited
  • Huvepharma, Inc.
  • Indian Immunologicals Ltd.
  • Intas Pharmaceuticals Ltd.
  • Laboratorio Drag Pharma Chile Invetec S.A.
  • Merck & Co., Inc.
  • Neogen Corporation
  • Nippon Zenyaku Kogyo Co., Ltd.
  • Norbrook Group
  • Nutramax Laboratories Veterinary Sciences, Inc
  • Orion Corporation
  • PetIQ, LLC
  • Phibro Animal Health Corporation
  • Teknofarma S.r.l.
  • Veterinary Pharmaceutical Solutions
  • Vetoquinol Group
  • Vetpharma Animal Health S.L. by Insud Pharma S.L.U.
  • Virbac S.A.
  • Zendal Group
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 47.54 Billion
Forecasted Market Value ( USD ) by 2032 $ 77.71 Billion
Compound Annual Growth Rate8.5%
Regions CoveredGlobal
No. of Companies Mentioned32

Related Topics

Related Reports

Veterinary Therapeutics Market - Global Forecast 2026-2032 - Product Image

Veterinary Therapeutics Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Europe Veterinary Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028 - Product Image

Europe Veterinary Pharmaceuticals Market, Competition, Forecast and Opportunities, 2018-2028

  • Report
  • 132 Pages
  • Europe
From
MEA Veterinary Pharmaceutical Market Forecasts from 2023 to 2028 - Product Image

MEA Veterinary Pharmaceutical Market Forecasts from 2023 to 2028

  • Report
  • 98 Pages
  • Africa, Middle East
From
A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products (November 2, 2027) - Product Image

A Practical Approach to Developing the CMC Package for Veterinary Pharmaceutical Products (November 2, 2027)

  • Training
  • 1 Day
  • Global
Veterinary Pharmaceuticals Market - Global Forecast 2026-2032 - Product Image

Veterinary Pharmaceuticals Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.